GeneGlobe ID: SBH0628645 | Cat. No.: | QuantiNova LNA PCR Assays for Real-Time PCR

HS_FMO1_1872521 QuantiNova LNA PCR Assay

Best coverage assay for FMO1
Assay targets 6 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Assay in Focus Panel

Select a variant to see the price

Product Specification

null
Assay name​
HS_FMO1_1872521 QuantiNova LNA PCR Assay
Assay specification​
Best coverage assay for FMO1
Assay targets 6 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Assay in Focus Panel
Gene symbol​
FMO1
Species​
Homo sapiens
Main target​
ENST00000354841
Exons numbers​
5-6
Ensembl exons ids​
ENSE00003541211;ENSE00000789743
Amplicon start​
944
Amplicon length​
92
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENST00000354841
Protein coding
CCDS1294
NM_001282692
Chr.1: 171257957 - 171285974
ENST00000367750
Protein coding
CCDS1294
NM_002021
Chr.1: 171248499 - 171285978
ENST00000402921
Protein coding
CCDS60351
NM_001282694
Chr.1: 171248471 - 171285978
ENST00000469112
Nonsense mediated decay
Chr.1: 171257738 - 171285977
ENST00000472893
Processed transcript
Chr.1: 171275346 - 171283196
ENST00000617670
Protein coding
CCDS1294
NM_001282693
Chr.1: 171248494 - 171285961
Introducing the HS_FMO1_1872521 QuantiNova LNA PCR Assay, a cutting-edge addition to our QuantiNova LNA PCR Assays for Digital PCR lineup, specifically designed for Digital PCR applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the HS_FMO1_1872521 QuantiNova LNA PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting Digital PCR, or any other sophisticated analyses, this product from our QuantiNova LNA PCR Assays for Digital PCR collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with HS_FMO1_1872521 QuantiNova LNA PCR Assay and elevate your work to new heights.